Goals And Background:
Premedication with pronase, dimethylpolysiloxane, and sodium bicarbonate improves visibility during upper gastrointestinal (UGI) endoscopy. However, the optimal time for this combination to take effect is unknown. We investigated the optimal time of pre-UGI endoscopy medication.
Study:
A randomized, investigator-blind, controlled trial. The 300 patients who were to receive premedication were randomized into 3 groups according to the following medication time before UGI endoscopy: 10 minutes (group A, n=98), 10 to 30 minutes (group B, n=97), and 30 minutes premedication (group C, n=99). Visibility scores (range, 1 to 4, with lower scores indicating better gastric mucosal visibility) were assessed for the antrum, lower body, upper body, and fundus and compared, including the sum of the scores, between the 3 groups.
Results:
Group B had significantly lower visibility scores for the lower body, upper body, and fundus than group C (P=0.001, 0.009, and 0.002, respectively). Group A obtained significantly lower scores for the antrum and lower body than group C (P=0.007 and 0.005, respectively). The total visibility scores of groups A and B were significantly lower compared with those of group C (P=0.001, 0.003, respectively).
Conclusions:
Administration of pronase, dimethylpolysiloxane, and sodium bicarbonate within 30 minutes before UGI endoscopy significantly improved endoscopic visualization. However, the optimal time to achieve the best visibility was between 10 to 30 minutes before UGI endoscopy.
Citing Articles
Optimal timing of simethicone administration prior to upper endoscopy: A multicenter, single-blind, randomized controlled trial.
Beaufort I, Verbeek R, Bosman J, Al-Toma A, Bogte A, Alvarez Herrero L
Endosc Int Open. 2023; 11(10):E992-E1000.
PMID: 37854124
PMC: 10581826.
DOI: 10.1055/a-2157-5034.
Pre-medication with simethicone and N-acetyl cysteine for improving mucosal visibility during upper gastrointestinal endoscopy: A randomized controlled trial.
Nabi Z, Vamsi M, Goud R, Sayyed M, Basha J, Reddy P
Indian J Gastroenterol. 2023; 43(5):986-994.
PMID: 37848768
DOI: 10.1007/s12664-023-01459-0.
Inadequate gastric preparation and its associated factors for magnetically controlled capsule endoscopy.
Kong Q, Peng C, Li Z, Tian B, Li Y, Chen F
Front Pharmacol. 2023; 14:1184754.
PMID: 37701026
PMC: 10493275.
DOI: 10.3389/fphar.2023.1184754.
The Effect of Using Premedication of Simethicone/Pronase With or Without Postural Change on Visualization of the Mucosa Before Endoscopy: A Prospective, Double Blinded, Randomized Controlled Trial.
Cao L, Zheng F, Wang D, Chen L, Feng X, Zhou Z
Clin Transl Gastroenterol. 2023; 15(2):e00625.
PMID: 37581331
PMC: 10887445.
DOI: 10.14309/ctg.0000000000000625.
[Recent research on the application of defoamers in children undergoing digestive endoscopy].
Gao J, Liu H
Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(5):541-545.
PMID: 37272183
PMC: 10247202.
DOI: 10.7499/j.issn.1008-8830.2301074.
Simethicone and N-acetyl cysteine combination as premedication before esophagogastroduodenoscopy: Double-blind randomized controlled trial.
Krishnamurthy V, Joseph A, Venkataraman S, Kurian G
Endosc Int Open. 2022; 10(5):E585-E592.
PMID: 35571469
PMC: 9106414.
DOI: 10.1055/a-1782-2003.
New endoscopic capsule vs upper gastrointestinal endoscopy in preoperative work-up of obese candidate for bariatric surgery: Relevance of a pilot study in the COVID-19 era.
Galloro G, Musella M, Siciliano S, Berardi G, Vitiello A, Velotti N
Endosc Int Open. 2022; 10(2):E183-E191.
PMID: 35178336
PMC: 8847058.
DOI: 10.1055/a-1723-3109.
Effect of premedication on lesion detection rate and visualization of the mucosa during upper gastrointestinal endoscopy: a multicenter large sample randomized controlled double-blind study.
Liu X, Guan C, Xue L, He S, Zhang Y, Zhao D
Surg Endosc. 2018; 32(8):3548-3556.
PMID: 29572630
PMC: 6061056.
DOI: 10.1007/s00464-018-6077-4.
Variation in preparation for gastroscopy: lessons towards safer and better outcomes.
Callaghan J, Neale J, Boger P, Sampson A, Patel P
Frontline Gastroenterol. 2017; 7(3):187-190.
PMID: 28839856
PMC: 5369482.
DOI: 10.1136/flgastro-2015-100647.
Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS).
Beg S, Ragunath K, Wyman A, Banks M, Trudgill N, Pritchard D
Gut. 2017; 66(11):1886-1899.
PMID: 28821598
PMC: 5739858.
DOI: 10.1136/gutjnl-2017-314109.
Effects of premedication with Pronase for endoscopic ultrasound of the stomach: A randomized controlled trial.
Wang G, Liu X, Wang S, Ge N, Guo J, Sun S
World J Gastroenterol. 2017; 22(48):10673-10679.
PMID: 28082820
PMC: 5192279.
DOI: 10.3748/wjg.v22.i48.10673.
Efforts to increase image quality during endoscopy: The role of pronase.
Kim G, Cho Y, Cha J, Lee S, Chung I
World J Gastrointest Endosc. 2016; 8(5):267-72.
PMID: 26981178
PMC: 4781907.
DOI: 10.4253/wjge.v8.i5.267.
Effect of pronase as mucolytic agent on imaging quality of magnifying endoscopy.
Kim G, Cho Y, Cha J, Lee S, Chung I
World J Gastroenterol. 2015; 21(8):2483-9.
PMID: 25741158
PMC: 4342927.
DOI: 10.3748/wjg.v21.i8.2483.
Effect of pronase premedication on narrow-band imaging endoscopy in patients with precancerous conditions of stomach.
Cha J, Won K, Chung I, Kim G, Lee S, Cho Y
Dig Dis Sci. 2014; 59(11):2735-41.
PMID: 24861034
DOI: 10.1007/s10620-014-3218-z.
Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication.
Liu K, Du F, Fu Q, Zhang W, Sun H, Zhang Y
Antimicrob Agents Chemother. 2014; 58(6):3348-53.
PMID: 24687504
PMC: 4068462.
DOI: 10.1128/AAC.02319-13.